Mitchel L. Zoler, PhD
News
ASH releases new VTE guidelines
November 28, 2018
A panel of the American Society of Hematology released more than 150 recommendations for dealing with venous thromboembolism.
News
CT opens extended window for stroke thrombolysis
November 1, 2018
MONTREAL – The new EXTEND findings “will have a major impact” on using an extended time window for thrombolysis in U.S. practice.
News
DAPT’s benefit after stroke or TIA clusters in first 21 days
October 19, 2018
MONTREAL – The superiority of clopidogrel plus aspirin over aspirin alone was apparent only during the first 21 days of treatment.
News
Smartphone device beat Holter for post-stroke AF detection
October 18, 2018
MONTREAL – In 294 post-stroke patients, atrial fibrillation screening with a smartphone-based device detected more cases than Holter monitoring.
News
GARFIELD-AF registry: DOACs cut mortality 19%
October 10, 2018
MUNICH – Results from a worldwide registry with more than 26,000 atrial fibrillation patients showed better survival with a direct oral anticoagulant.
News
Pregnancy boosts cardiac disease mortality nearly 100-fold
September 12, 2018
MUNICH – Registry data from more than 5,700 women with cardiac disease who became pregnant provide insight on complication rates.
News
Coronary CT angiography radiation dose fell 78% from 2007-2017
September 11, 2018
MUNICH – A 2017 survey of coronary CT angiography radiation doses for 4,502 patients at 61 worldwide sites showed a 78% drop compared with 2007.
News
New MI definition aims to better distinguish infarction from injury
August 28, 2018
MUNICH – By endorsing high sensitivity cardiac troponin and cardiac MR as diagnostic cornerstones, the new MI definition stands to change U.S. practice.
News
Primary cirrhotic prophylaxis of bacterial peritonitis falls short
July 9, 2018
A review of prospective data from 308 cirrhotic patients on antibiotic prophylaxis highlights the limitations of this treatment.
News
DOAC’s edge over warfarin fades with low adherence
June 12, 2018
BOSTON – When atrial fib patients adhere to a direct oral anticoagulant it outperforms warfarin, but when compliance falls the tables get turned.